Immunogenicity of biologics in inflammatory bowel disease.

about

Immunogenicity of biologics in inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q49404676

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Immunogenicity of biologics in inflammatory bowel disease.

@en

Immunogenicity of biologics in inflammatory bowel disease.

@nl

type

Item

label

Immunogenicity of biologics in inflammatory bowel disease.

@en

Immunogenicity of biologics in inflammatory bowel disease.

@nl

prefLabel

Immunogenicity of biologics in inflammatory bowel disease.

@en

Immunogenicity of biologics in inflammatory bowel disease.

@nl

P1476

Immunogenicity of biologics in inflammatory bowel disease.

@en

P2093

Amy Marren

http://www.w3.org/2001/XMLSchema#string

Ann Gils

http://www.w3.org/2001/XMLSchema#string

Paola Accossato

http://www.w3.org/2001/XMLSchema#string

Sadiq Lula

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of inflammatory bowel disease in adults

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Certolizumab pegol for the treatment of Crohn's disease

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease.

Current and emerging biologics for ulcerative colitis.

Management of Crohn's disease in adults.

P304

1756283X17750355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X17750355

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Séverine Vermeire

P577

2018-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29383030

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

5784568

http://www.w3.org/2001/XMLSchema#string